{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T11:13:28Z","timestamp":1773486808747,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.jconrel.2008.07.031","type":"journal-article","created":{"date-parts":[[2008,7,31]],"date-time":"2008-07-31T09:25:17Z","timestamp":1217496317000},"page":"220-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Prevention of MDR development in leukemia cells by micelle-forming polymeric surfactant"],"prefix":"10.1016","volume":"131","author":[{"given":"Amit K.","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valery Yu.","family":"Alakhov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena V.","family":"Batrakova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander V.","family":"Kabanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jconrel.2008.07.031_bib1","doi-asserted-by":"crossref","first-page":"E128","DOI":"10.1208\/aapsj0902015","article-title":"Targeted pharmaceutical nanocarriers for cancer therapy and imaging","volume":"9","author":"Torchilin","year":"2007","journal-title":"AAPS J."},{"issue":"6","key":"10.1016\/j.jconrel.2008.07.031_bib2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/10611860600833880","article-title":"Polymer conjugates for drug targeting. From inspired to inspiration!","volume":"14","author":"Duncan","year":"2006","journal-title":"J. Drug Target."},{"issue":"3","key":"10.1016\/j.jconrel.2008.07.031_bib3","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jconrel.2006.03.001","article-title":"In-vivo efficacy of novel paclitaxel nanoparticles in paclitaxel-resistant human colorectal tumors","volume":"112","author":"Koziara","year":"2006","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.jconrel.2008.07.031_bib4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jconrel.2006.02.014","article-title":"Etoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous P-glycoprotein inhibition","volume":"112","author":"Lamprecht","year":"2006","journal-title":"J. Control. Release"},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2008.07.031_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jconrel.2005.11.011","article-title":"Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine","volume":"111","author":"Werle","year":"2006","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2008.07.031_bib6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jconrel.2006.10.007","article-title":"Impact of intraperitoneal, sustained delivery of paclitaxel on the expression of P-glycoprotein in ovarian tumors","volume":"117","author":"Ho","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2008.07.031_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2008.04.013","article-title":"Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers","author":"Batrakova","year":"2008","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.jconrel.2008.07.031_bib8","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/sj.bjc.6601856","article-title":"Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer","volume":"90","author":"Danson","year":"2004","journal-title":"Br. J. Cancer"},{"issue":"10","key":"10.1016\/j.jconrel.2008.07.031_bib9","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1038\/sj.bjc.6602204","article-title":"Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin","volume":"91","author":"Matsumura","year":"2004","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.jconrel.2008.07.031_bib10","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1349-7006.2002.tb01229.x","article-title":"Incorporation of the anticancer agent KRN5500 into polymeric micelles diminishes the pulmonary toxicity","volume":"93","author":"Mizumura","year":"2002","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.jconrel.2008.07.031_bib11","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1200\/jco.2006.24.18_suppl.4080","article-title":"SP1049C as first-line therapy in advanced (inoperable or metastatic) adenocarcinoma of the oesophagus: a phase II window study","volume":"24(18S)","author":"Armstrong","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.jconrel.2008.07.031_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v19.i1.10","article-title":"Pluronic block copolymers in drug delivery: from micellar nanocontainers to biological response modifiers","volume":"19","author":"Kabanov","year":"2002","journal-title":"Crit. Rev. Ther. Drug Carr. Syst."},{"issue":"2","key":"10.1016\/j.jconrel.2008.07.031_bib13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1021\/bc950093n","article-title":"Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer","volume":"7","author":"Alakhov","year":"1996","journal-title":"Bioconjug. Chem."},{"issue":"5","key":"10.1016\/j.jconrel.2008.07.031_bib14","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0169-409X(02)00047-9","article-title":"Pluronic block copolymers for overcoming drug resistance in cancer","volume":"54","author":"Kabanov","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"16","key":"10.1016\/j.jconrel.2008.07.031_bib15","first-page":"3626","article-title":"Hypersensitizing effect of pluronic L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin in multiple drug-resistant cells","volume":"56","author":"Venne","year":"1996","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.jconrel.2008.07.031_bib16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP-dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.jconrel.2008.07.031_bib17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10555-007-9042-6","article-title":"ABCG2: determining its relevance in clinical drug resistance","volume":"26","author":"Robey","year":"2007","journal-title":"Cancer Metastasis Rev."},{"issue":"3","key":"10.1016\/j.jconrel.2008.07.031_bib18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd1984","article-title":"Targeting multidrug resistance in cancer","volume":"5","author":"Szakacs","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.jconrel.2008.07.031_bib19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1073\/pnas.84.1.265","article-title":"Expression of a multidrug-resistance gene in human tumors and tissues","volume":"84","author":"Fojo","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.jconrel.2008.07.031_bib20","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/0006-291X(89)92761-7","article-title":"The direct activation of human multidrug resistance gene (MDR1) by anticancer agents","volume":"165","author":"Kohno","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.jconrel.2008.07.031_bib21","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1586\/14737140.7.4.447","article-title":"Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor","volume":"7","author":"Fox","year":"2007","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"2","key":"10.1016\/j.jconrel.2008.07.031_bib22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/107327480301000207","article-title":"Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein","volume":"10","author":"Thomas","year":"2003","journal-title":"Cancer Control"},{"issue":"Pt 1","key":"10.1016\/j.jconrel.2008.07.031_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1042\/BST0330241","article-title":"ABC transporters in the balance: is there a role in multidrug resistance?","volume":"33","author":"Polgar","year":"2005","journal-title":"Biochem. Soc. Trans."},{"issue":"7","key":"10.1016\/j.jconrel.2008.07.031_bib24","first-page":"711","article-title":"Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia","volume":"85","author":"Wuchter","year":"2000","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.jconrel.2008.07.031_bib25","first-page":"393","article-title":"P-glycoprotein expression in adult acute myeloid leukemia: correlation with induction treatment outcome","volume":"48","author":"Tothova","year":"2001","journal-title":"Neoplasma"},{"issue":"1A","key":"10.1016\/j.jconrel.2008.07.031_bib26","first-page":"367","article-title":"Reversal of multidrug resistance of cancer cells in vitro: modification of drug resistance by selected carotenoids","volume":"26","author":"Gyemant","year":"2006","journal-title":"Anticancer Res."},{"issue":"3","key":"10.1016\/j.jconrel.2008.07.031_bib27","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1158\/1078-0432.1342.11.3","article-title":"Recombinant adeno-associated virus 2-mediated antiangiogenic prevention in a mouse model of intraperitoneal ovarian cancer","volume":"11","author":"Isayeva","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.jconrel.2008.07.031_bib28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0022-1759(90)90187-Z","article-title":"MTT colorimetric assay for testing macrophage cytotoxic activity in vitro","volume":"131","author":"Ferrari","year":"1990","journal-title":"J. Immunol. Methods"},{"issue":"12","key":"10.1016\/j.jconrel.2008.07.031_bib29","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1054\/bjoc.2001.2165","article-title":"Mechanism of sensitization of MDR cancer cells by pluronic block copolymers: selective energy depletion","volume":"85","author":"Batrakova","year":"2001","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.jconrel.2008.07.031_bib30","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1021\/bc970118d","article-title":"Interactions of pluronic block copolymers with brain microvessel endothelial cells: evidence of two potential pathways for drug absorption","volume":"8","author":"Miller","year":"1997","journal-title":"Bioconjug. Chem."},{"issue":"1","key":"10.1016\/j.jconrel.2008.07.031_bib31","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1186\/gb-2003-4-1-r5","article-title":"Assessing unmodified 70-mer oligonucleotide probe performance on glass-slide microarrays","volume":"4","author":"Wang","year":"2003","journal-title":"Genome Biol."},{"issue":"2","key":"10.1016\/j.jconrel.2008.07.031_bib32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1021\/mp050050g","article-title":"Alteration of genomic responses to doxorubicin and prevention of MDR in breast cancer cells by a polymer excipient: pluronic P85","volume":"3","author":"Batrakova","year":"2006","journal-title":"Mol. Pharmacol."},{"issue":"10","key":"10.1016\/j.jconrel.2008.07.031_bib33","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s002680010200","article-title":"Molecular analysis of mechanisms regulating drug sensitivity and the development of new chemotherapy strategies for genitourinary carcinomas","volume":"24","author":"Naito","year":"2000","journal-title":"World J. Surg."},{"issue":"8","key":"10.1016\/j.jconrel.2008.07.031_bib34","first-page":"3205","article-title":"P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia","volume":"6","author":"van der Kolk","year":"2000","journal-title":"Clin. Cancer Res."},{"issue":"47","key":"10.1016\/j.jconrel.2008.07.031_bib35","doi-asserted-by":"crossref","first-page":"7512","DOI":"10.1038\/sj.onc.1206951","article-title":"Strategies for reversing drug resistance","volume":"22","author":"Fojo","year":"2003","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.jconrel.2008.07.031_bib36","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/bjc.1996.587","article-title":"Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles: in vivo evaluation of anti-cancer activity","volume":"74","author":"Batrakova","year":"1996","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2008.07.031_bib37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0927-7765(99)00064-8","article-title":"Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials","volume":"16","author":"Alakhov","year":"1999","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"9","key":"10.1016\/j.jconrel.2008.07.031_bib38","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1023\/A:1018942823676","article-title":"Fundamental relationships between the composition of pluronic block copolymers and their hypersensitization effect in MDR cancer cells","volume":"16","author":"Batrakova","year":"1999","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2008.07.031_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-4652(199810)177:1<1::AID-JCP1>3.0.CO;2-R","article-title":"Increased P-glycoprotein messenger RNA stability in rat liver tumors in vivo","volume":"177","author":"Lee","year":"1998","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.jconrel.2008.07.031_bib40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0026-895X(25)08523-2","article-title":"Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cells","volume":"47","author":"Muller","year":"1995","journal-title":"Mol. Pharmacol."},{"issue":"54","key":"10.1016\/j.jconrel.2008.07.031_bib41","doi-asserted-by":"crossref","first-page":"8061","DOI":"10.1038\/sj.onc.1208955","article-title":"Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs","volume":"24","author":"Baker","year":"2005","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.jconrel.2008.07.031_bib42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0092-8674(91)90141-K","article-title":"Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells","volume":"66","author":"Chaudhary","year":"1991","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.jconrel.2008.07.031_bib43","first-page":"799","article-title":"Lack of correlation between expression and function of P-glycoprotein in acute myeloid leukemia cell lines","volume":"9","author":"Bailly","year":"1995","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.jconrel.2008.07.031_bib44","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1159\/000226881","article-title":"Development of a mitoxantrone-resistant P 388 in vivo: approaches to overcome resistance","volume":"47","author":"Fichtner","year":"1990","journal-title":"Oncology"},{"issue":"5A","key":"10.1016\/j.jconrel.2008.07.031_bib45","first-page":"1995","article-title":"Characterization of four drug-resistant P388 sublines: resistance\/sensitivity in vivo, resistance- and proliferation-markers, immunogenicity","volume":"14","author":"Fichtner","year":"1994","journal-title":"Anticancer Res."},{"issue":"3","key":"10.1016\/j.jconrel.2008.07.031_bib46","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0006-2952(00)00337-3","article-title":"Characterisation of non-P-glycoprotein multidrug-resistant Ehrlich ascites tumour cells selected for resistance to mitoxantrone","volume":"60","author":"Nielsen","year":"2000","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.jconrel.2008.07.031_bib47","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0006-2952(00)00338-5","article-title":"Characterisation of multidrug-resistant Ehrlich ascites tumour cells selected in vivo for resistance to etoposide","volume":"60","author":"Nielsen","year":"2000","journal-title":"Biochem. Pharmacol."},{"issue":"9","key":"10.1016\/j.jconrel.2008.07.031_bib48","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/bjc.1998.650","article-title":"P-glycoprotein expression in Ehrlich ascites tumour cells after in vitro and in vivo selection with daunorubicin","volume":"78","author":"Nielsen","year":"1998","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.jconrel.2008.07.031_bib49","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jconrel.2004.09.002","article-title":"Distribution kinetics of a micelle-forming block copolymer pluronic P85","volume":"100","author":"Batrakova","year":"2004","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.jconrel.2008.07.031_bib50","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0306-3623(95)02013-6","article-title":"Cellular resistance to anthracyclines","volume":"27","author":"Nielsen","year":"1996","journal-title":"Gen. Pharmacol."},{"issue":"15","key":"10.1016\/j.jconrel.2008.07.031_bib51","first-page":"4161","article-title":"Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray","volume":"60","author":"Kudoh","year":"2000","journal-title":"Cancer Res."},{"issue":"14","key":"10.1016\/j.jconrel.2008.07.031_bib52","first-page":"3844","article-title":"Adriamycin activation and oxygen free radical formation in human breast tumor cells: protective role of glutathione peroxidase in adriamycin resistance","volume":"49","author":"Sinha","year":"1989","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.jconrel.2008.07.031_bib53","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ijc.2910490427","article-title":"Induction of multiple-drug resistance during anti-neoplastic chemotherapy in vitro","volume":"49","author":"Licht","year":"1991","journal-title":"Int. J. Cancer"},{"issue":"10","key":"10.1016\/j.jconrel.2008.07.031_bib54","first-page":"3193","article-title":"In vitro prevention of the emergence of multidrug resistance in a pediatric rhabdomyosarcoma cell line","volume":"7","author":"Cocker","year":"2001","journal-title":"Clin. Cancer Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365908004197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365908004197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:22:30Z","timestamp":1759159350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365908004197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0168365908004197"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2008.07.031","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of MDR development in leukemia cells by micelle-forming polymeric surfactant","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2008.07.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}